Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 29

1.

Machine learning-based identification and rule-based normalization of adverse drug reactions in drug labels.

Tiftikci M, Özgür A, He Y, Hur J.

BMC Bioinformatics. 2019 Dec 23;20(Suppl 21):707. doi: 10.1186/s12859-019-3195-5.

2.

A statistical analysis of vaccine-adverse event data.

Ren JJ, Sun T, He Y, Zhang Y.

BMC Med Inform Decis Mak. 2019 May 28;19(1):101. doi: 10.1186/s12911-019-0818-8.

3.

ODAE: Ontology-based systematic representation and analysis of drug adverse events and its usage in study of adverse events given different patient age and disease conditions.

Yu H, Nysak S, Garg N, Ong E, Ye X, Zhang X, He Y.

BMC Bioinformatics. 2019 May 1;20(Suppl 7):199. doi: 10.1186/s12859-019-2729-1.

4.

Ontology-based literature mining and class effect analysis of adverse drug reactions associated with neuropathy-inducing drugs.

Hur J, Özgür A, He Y.

J Biomed Semantics. 2018 Jun 7;9(1):17. doi: 10.1186/s13326-018-0185-x.

5.

Ontology-Based Meta-Analysis of Animal and Human Adverse Events Associated With Licensed Brucellosis Vaccines.

Xie J, Wang J, Li Z, Wang W, Pang Y, He Y.

Front Pharmacol. 2018 May 15;9:503. doi: 10.3389/fphar.2018.00503. eCollection 2018.

7.

Ontology-based systematic representation and analysis of traditional Chinese drugs against rheumatism.

Liu Q, Wang J, Zhu Y, He Y.

BMC Syst Biol. 2017 Dec 21;11(Suppl 7):130. doi: 10.1186/s12918-017-0510-5.

8.
9.

Ontology-Based Vaccine Adverse Event Representation and Analysis.

Xie J, He Y.

Adv Exp Med Biol. 2017;1028:89-103. doi: 10.1007/978-981-10-6041-0_6. Review.

PMID:
29058218
10.

Integrative representations and analyses of vaccine-induced intended protective immunity and unintended adverse events using ontology-based and theory-guided approaches.

He Y, Ong E, Xie J.

Glob Vaccines Immunol. 2016 Jun;1(2):37-39. doi: 10.15761/GVI.1000110. Epub 2016 May 23. No abstract available.

12.
13.
15.

Ontology-based collection, representation and analysis of drug-associated neuropathy adverse events.

Guo A, Racz R, Hur J, Lin Y, Xiang Z, Zhao L, Rinder J, Jiang G, Zhu Q, He Y.

J Biomed Semantics. 2016 May 21;7:29. doi: 10.1186/s13326-016-0069-x. eCollection 2016.

16.

Linking MedDRA(®)-Coded Clinical Phenotypes to Biological Mechanisms by the Ontology of Adverse Events: A Pilot Study on Tyrosine Kinase Inhibitors.

Sarntivijai S, Zhang S, Jagannathan DG, Zaman S, Burkhart KK, Omenn GS, He Y, Athey BD, Abernethy DR.

Drug Saf. 2016 Jul;39(7):697-707. doi: 10.1007/s40264-016-0414-0.

17.

Vaccine and Drug Ontology Studies (VDOS 2014).

Tao C, He Y, Arabandi S.

J Biomed Semantics. 2016 Feb 25;7:6. doi: 10.1186/s13326-015-0039-8. eCollection 2016.

18.

OAE: The Ontology of Adverse Events.

He Y, Sarntivijai S, Lin Y, Xiang Z, Guo A, Zhang S, Jagannathan D, Toldo L, Tao C, Smith B.

J Biomed Semantics. 2014 Jul 5;5:29. doi: 10.1186/2041-1480-5-29. eCollection 2014.

19.

The ontology of genetic susceptibility factors (OGSF) and its application in modeling genetic susceptibility to vaccine adverse events.

Lin Y, He Y.

J Biomed Semantics. 2014 Apr 30;5:19. doi: 10.1186/2041-1480-5-19. eCollection 2014.

20.

Ontology-supported research on vaccine efficacy, safety and integrative biological networks.

He Y.

Expert Rev Vaccines. 2014 Jul;13(7):825-41. doi: 10.1586/14760584.2014.923762. Epub 2014 Jun 7. Review.

Supplemental Content

Loading ...
Support Center